BLX-883

BLX-883 Uses, Dosage, Side Effects, Food Interaction and all others data.

BLX-883 is a form of alfa interferon developed by Biolex for the treatment of hepatitis viral C. Alfa interferon is used in the treatment of hepatitis C, hepatitis B, and multiple cancers and its worldwide sales currently exceed $3 billion.

Table Of contents

• BLX-883
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	BLX-883
Generic	BLX-883
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in hepatitis (viral, C).

How BLX-883 works

BLX-883 is the first clinical-stage therapeutic candidate produced in Biolex' GMP facilities using its proprietary Lex System.

Innovators Monograph

You find simplified version here BLX-883